Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2007
04/19/2007US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
04/19/2007US20070088018 Cb1 antagonist compounds
04/19/2007DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases
04/19/2007CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases
04/19/2007CA2625687A1 Antibacterial active 5-chinolin derivative
04/19/2007CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
04/19/2007CA2623535A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators
04/19/2007CA2623500A1 Kinase inhibitors
04/19/2007CA2623202A1 Hydrazide compound and pesticidal use of the same
04/19/2007CA2622755A1 Mek inhibitors and methods of their use
04/19/2007CA2621038A1 Triarylcarboxylic acid derivative
04/18/2007EP1775295A1 Vanilloid receptor ligands and their use in treatments
04/18/2007EP1775293A1 Antiplatelet agent and process for producing the same
04/18/2007EP1775292A1 Salts of benzimidazole derivative with amines and process for production thereof
04/18/2007EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
04/18/2007EP1773828A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773817A1 Substituted aryl-amine derivatives and methods of use
04/18/2007EP1773815A2 Mitotic kinesin inhibitors
04/18/2007EP1773814A2 Substituted oxindol derivatives and medicaments containing the same
04/18/2007EP1773813A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate
04/18/2007EP1773812A1 3-pyridinylethylcarboxamide derivatives as fungicides
04/18/2007EP1773811A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt
04/18/2007EP1773810A1 New 4-benzylidene-piperidin derivatives
04/18/2007EP1773809A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
04/18/2007EP1773808A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
04/18/2007EP1773807A2 Kinase inhibitors
04/18/2007EP1773806A1 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi
04/18/2007EP1773805A1 Quinazolin-4-yl-piperidine and cinnolin-4-yl-piperidine derivatives as pde10 inhibitors for the treatment of cns disorders
04/18/2007EP1773797A2 Aromatic compounds
04/18/2007EP1773788A2 Quinazoline derivatives
04/18/2007EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors
04/18/2007EP1773784A2 Anti-inflammatory medicaments
04/18/2007EP1773781A2 Indazoles useful in treating cardiovascular diseases
04/18/2007EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors
04/18/2007EP1773771A2 Compounds and methods for treatment of thrombosis
04/18/2007EP1773770A1 Indole-2-carboxamidine derivatives as nmda receptor antagonists
04/18/2007EP1773768A2 Pyrrole derivatives as pharmaceutical agents
04/18/2007EP1773763A1 Lysine based compounds
04/18/2007EP1773347A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/18/2007EP1773338A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/18/2007EP1773337A2 Modulators of nuclear receptors
04/18/2007EP1773330A2 Substituted pyrazoles, compositions containing such compounds and methods of use
04/18/2007EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
04/18/2007EP1542989B1 Protein tyrosine kinase inhibitors
04/18/2007EP1514115B1 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
04/18/2007EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
04/18/2007EP1425276B1 Heterocyclic carboxamides and their use as fungicides
04/18/2007EP1406893B1 Pyrrolidine bicyclic compounds
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1036066B1 Substituted pyrimidine and pyridine herbicides
04/18/2007EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR
04/18/2007CN1950393A Novel inhibitors of hepatitis c virus ns3 protease
04/18/2007CN1950365A Indolyl derivatives as liver-X-receptor modulators
04/18/2007CN1950359A Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an IKB kinase inhibitor
04/18/2007CN1950358A Novel gamma secretase inhibitors
04/18/2007CN1950357A Imidazole derivatives used as TAFIA inhibitors
04/18/2007CN1950343A Basic amine compound and use thereof
04/18/2007CN1950340A LXR receptor modulators
04/18/2007CN1950086A Fluorinated 4-azasteroids as androgen receptor modulators
04/18/2007CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
04/18/2007CN1950081A Arylalkylamino-substituted quinazoline analogues
04/18/2007CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof
04/18/2007CN1948286A Salt of carboxylic acid containing N-substituted succinimide thio group and unvulcanized rubber composition containing the same
04/18/2007CN1310909C Novel heteroaryl derivatives, their prepn. and use
04/18/2007CN1310906C Indole-type derivatives as inhibitors of p38 kinase
04/18/2007CN1310642C Methods and compositions to enhance white blood cell count
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007USRE39574 Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
04/17/2007US7205417 Spiro compounds
04/17/2007US7205411 for treatment of neuropathic pain
04/17/2007US7205410 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting
04/17/2007US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators
04/17/2007US7205408 Therapy for bacteria infections in mammals
04/17/2007US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide
04/17/2007US7205328 Aids viricide
04/17/2007US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes
04/17/2007US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders
04/17/2007US7205317 Pain management
04/17/2007US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
04/17/2007US7205314 Compounds for the treatment of dementia related diseases
04/17/2007US7205313 Central nervous system disorders; analgesics; headaches
04/17/2007US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
04/17/2007US7205309 Obesity therapy; administering orlistat
04/17/2007US7205307 Pyrimidines as novel openers of potassium ion channels
04/17/2007US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
04/17/2007US7205305 Inhibitors of p38
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205303 Substituted heterocyclic compounds
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/17/2007US7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
04/17/2007US7205300 Aryl fused azapolycyclic compounds
04/17/2007US7205299 Indole derivatives having an apoptosis-inducing effect
04/17/2007US7205298 Substituted triazine kinase inhibitors
04/17/2007US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity
04/17/2007US7205294 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions
04/17/2007US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches
04/17/2007CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists
04/17/2007CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors